Ieri 28 settembre 2026, presso il Dipartimento di Farmacia dell’Università degli Studi di Napoli Federico II, si è tenuta la terza e ultima sessione d’esame finale del Master di II livello in Sviluppo Preclinico e Clinico del Farmaco e Monitoraggio Post-marketing.
Ieri, 25 marzo 2026, si è tenuto il primo esame finale del Master in “Sviluppo preclinico e clinico del farmaco e monitoraggio post‑marketing” aa 2024-2025.
Elenco iscritti al Master
| Cookie | Durata | Descrizione |
|---|---|---|
| cookielawinfo-checbox-analytics | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics". |
| cookielawinfo-checbox-functional | 11 months | The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional". |
| cookielawinfo-checbox-others | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other. |
| cookielawinfo-checkbox-necessary | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary". |
| cookielawinfo-checkbox-performance | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance". |
| viewed_cookie_policy | 11 months | The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data. |